January 25, 2012 |
Jackie Fedeli |
No Comments
Every Five seconds, there is an automobile accident somewhere in the United States. Half involve some sort of injury. Your First thought after an auto accident might be to call your insurance company and let them handle all of the details. For some this may be the best option. Others may contact an attorney to file a lawsuit against the negligent driver on their behalf. If you were involved in an auto accident, you may want to ask yourself what are the reason to file a lawsuit after a car accident? more »
January 20, 2012 |
Michael Monheit |
No Comments
The answer to the question, “is Actos off the market” is dependent on which market you are talking about. Despite warnings, the FDA has allowed Actos to remain on the market in the United States. Yet, several European countries including France and Germany have taken Actos off the market at least in part because of the possible connection between Actos and bladder cancer. Additionally, the FDA has warned physicians not to prescribe Actos to patients who have active bladder cancer or who have a history of bladder cancer. more »
January 19, 2012 |
Jackie Fedeli |
No Comments
Actos is a prescription drug containing Pioglitazone Hydrochloride. This medication, manufactured by Takeda pharmaceuticals was approved by the FDA in July 1999 to treat diabetes. Since its introduction to the market, Actos was the subject of a 10 year study to measure the safety and side effects. At the 5-year interval, results showed that although there was no overall increase of bladder cancer from Actos – there was an increased risk of bladder cancer noted among patients who had the longest exposure to Actos and were exposed to the highest cumulative dose of Actos. However, following the completion of the 10 year study, on June 15, 2011, the FDA issued a safety alert informing the public that using the diabetes Actos for more than one year may put patients at a higher risk for bladder cancer. more »
January 17, 2012 |
Deborah Forrister |
No Comments
According to a recent article in the New York Times, experts estimate that the cost of hip implant failures will likely cost insurers, employers, taxpayers and others billions of dollars in the years to come.
DePuy hip replacement problems are included in the cost of hip implant failures although the makers of other hip implants have problems too.
Metal on metal or MoM hip implants have high rates of failures. Meant to last 15 years or more, some are lasting a few years. Worse, the wear and tear of metal on metal causes metal debris to go into the bloodstream and body tissues. The wear and tear of metal causes excessive pain and cobalt poisoning. more »
January 12, 2012 |
Michael Monheit |
No Comments
Imagine that you worked many years for an employer — for good pay — only to find after retirement that your job exposed you to long-term health risks, including brain injury. Your former bosses protest that you were compensated well enough during your professional years that you need no additional compensation. Where do you turn? more »
January 12, 2012 |
Jackie Fedeli |
No Comments
As the world welcomed a new year, on January 1, 2012, The shareholders at Anapol Schwartz welcomed another member to their table. Gregory Spizer a non-equity partner at Anapol Schwartz became an Equity Partner and Firm Shareholder. more »
January 10, 2012 |
Jackie Fedeli |
No Comments
Topamax, and it’s generic, topiramate, is used to treat epileptic seizures. It is also occasionally prescribed to treat migraines. The issue is not whether or not Topamax is effective in preventing seizures, the problem lies with the risks it poses to women of childbearing age. more »
January 5, 2012 |
Jackie Fedeli |
1 Comment
A few months ago, the FDA warned that Transvaginal Mesh used to treat Pelvic Organ Prolapse and Stress Urinary Incontinence was riskier than other treatments for these conditions, and that doctors and patients should explore all other options before going through with this surgery. Since then, the FDA had been leaning towards making Transvaginal Mesh a high risk device. Yesterday, the FDA issued an order requiring makers of implantable mesh used to treat urinary incontinence in women to study the risks. more »
January 3, 2012 |
Thomas Anapol |
No Comments
Since the link between Asbestos and Mesothelioma was discovered in the 1950s, regulations have been put into place for manufacturers and builders who would have used this product. Although you or a loved one may have been exposed to asbestos in the 1980s, it’s not too late to file Pennsylvania Asbestos Lawsuits. Lung Cancer Adenocarcinoma, the most common type of asbestos cancer, can take up to 20 or 30 years to completely manifest in individuals with prolonged asbestos exposure. more »
December 19, 2011 |
Michael Monheit |
No Comments
Has Fosamax Left the Building?
In this case the building is your body and women have started asking: How long for Fosamax to clear the system, my system, my body?
How many times have you heard: “Your body is your temple?” You may or may not agree but you only have one body and hopefully do the best you can to care for it.
Women who take Fosamax to prevent osteoporosis and build bone density are prescribed Fosamax long term. Fosamax is not like a round of antibiotics that you take for 10 days. Fosamax is prescribed long term. It’s not unusual for a woman to be prescribed Fosamax for 5 years, 10 years, and more.
more »